| Literature DB >> 35308051 |
Kira E Riehm1, Elena Badillo Goicoechea1, Frances M Wang1, Esther Kim2, Luke R Aldridge1, Carly P Lupton-Smith1, Rachel Presskreischer1, Ting-Hsuan Chang1, Sarah LaRocca2, Frauke Kreuter3,4,5, Elizabeth A Stuart1.
Abstract
Objectives: To examine the association of non-pharmaceutical interventions (NPIs) with anxiety and depressive symptoms among adults and determine if these associations varied by gender and age.Entities:
Keywords: COVID-19; age; anxiety; depression; gender; non-pharmaceutical interventions
Mesh:
Year: 2022 PMID: 35308051 PMCID: PMC8927027 DOI: 10.3389/ijph.2022.1604430
Source DB: PubMed Journal: Int J Public Health ISSN: 1661-8556 Impact factor: 3.380
FIGURE 1Temporal Trends in Policies [Panel (A)] and Prevalence of Anxiety and Depressive Symptoms [Panel (B)] (43 countries, 2020).
Demographic Characteristics of COVID-19 Trends and Impact Survey Respondents (n=16,177,184, 43 countries, 2020).
| Variable | Weighted Percentage (%) |
|---|---|
| Female | 44.3 |
| Age | |
| 18–24 | 16.9 |
| 25–34 | 26.8 |
| 35–44 | 19.3 |
| 45–54 | 16.4 |
| 55–64 | 9.8 |
| 65+ | 10.8 |
| Urban | 53.1 |
| Works Outside Home | 35.2 |
| Anxiety | 4.8 |
| Depression | 6.8 |
Notes: aN for anxiety symptoms is 16,083,027.
N for depressive symptoms is 16,163,821.
Association of the Stringency Index with Anxiety (n = 16,083,027) and Depressive Symptoms (n = 16,163,821) Among Adults (43 countries, 2020).
| Variable | Anxiety symptoms | Depressive symptoms | ||
|---|---|---|---|---|
| OR | 95% CI | OR | 95% CI | |
| Stringency Index | 1.014 | 1.008, 1.019 | 1.027 | 1.022, 1.032 |
| Economic Support Index | 0.987 | 0.984, 0.990 | 0.991 | 0.998, 0.994 |
| Weekly COVID-19 cases | 1.001 | 0.990, 1.011 | 1.017 | 1.008, 1.027 |
| Weekly COVID-19 deaths | 1.040 | 1.030, 1.051 | 1.019 | 1.009, 1.028 |
| Female (ref = male) | 1.489 | 1.475, 1.504 | 1.418 | 1.406, 1.431 |
| Age in years (ref = 65+) | ||||
| 18–24 | 4.428 | 4.318, 4.541 | 6.348 | 6.209, 6.490 |
| 25–34 | 3.147 | 3.070, 3.226 | 3.862 | 3.778, 3.948 |
| 35–44 | 2.411 | 2.352, 2.473 | 2.564 | 2.507, 2.623 |
| 45–54 | 1.919 | 1.870, 1.969 | 1.975 | 1.930, 2.021 |
| 55–64 | 1.444 | 1.403, 1.485 | 1.495 | 1.458, 1.534 |
| Urban (ref = town/village/rural) | 1.050 | 1.039, 1.062 | 1.071 | 1.061, 1.081 |
| Works Outside Home (ref = no) | 1.069 | 1.059, 1.080 | 0.977 | 0.968, 0.986 |
Note: Models include fixed effects for country and calendar time (month).
Variables lagged to the week prior to survey date.
FIGURE 2Odds Ratios and 95% Confidence Intervals for Associations of Non-Pharmaceutical Interventions with Anxiety and Depressive Symptoms, Stratified by Gender (43 countries, 2020).
FIGURE 3Odds Ratios and 95% Confidence Intervals for Associations of Non-Pharmaceutical Interventions with Anxiety and Depressive Symptoms, Stratified by Age (43 countries, 2020).